Changes are sweeping the pharmaceutical landscape. Tightening DSCSA regulations, increased demand for personalized medicine, evolving cybersecurity threats, and shifting standards for manufacturers, are all surfacing new challenges – and new opportunities.
Evolution can help you seize them through smarter, safer, sleeker product packaging that meets regulations and patient needs while conveying your message effectively.
We have the specialist knowledge to advise pharmaceutical companies at all stages of the product lifecycle. During Phase III, we shift our focus to a new priority: evaluating the viability of the product based on predicted or finalized pivotal trial results. At this stage, it’s time to ask – and answer – questions like, how will the product realistically fare, given these results and approved status? And what sort of device or packaging should I use for my pharmaceutical product?
The answer to the second question can change the answer to the first. By incorporating actual customer feedback and behavioral data into your pharmaceutical packaging design strategy, you can better connect with your target patient markets – and influence the patient decision-making journey.
For more about Evolution’s packaging for consumer products, please visit our consumer services packaging page.
The Evolution team is comprised of industry veterans with decades of experience in pharmaceutical marketing research. We’re trusted leaders who have worked with Fortune 500 companies and major biopharmaceutical firms, including 15 of the top 20 global pharmaceutical firms. Industry leaders know us, trust us, and keep coming back for more. Let us show you why.